Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kirsten L. Bell Burdett"'
Autor:
Mykhaylo D. Krushelnytskyy, Mark W. Youngblood, Maciej S. Lesniak, Hanna R. Kemeny, Luis G. Fernandez, Kirsten L. Bell Burdett, Hui Zhang, Tord D. Alden, Nader S. Dahdaleh
Publikováno v:
Journal of Clinical Neuroscience. 105:86-90
Handoffs and documentation are a potentially modifiable source of medical error. However, little attention has been given toenhancementof these within the neurosurgical field. We aim to increase efficiency and accuracy of neurosurgical handoffs, incl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::674d0a6440c0ce874194636c028c95a0
https://doi.org/10.1016/j.jocn.2022.09.007
https://doi.org/10.1016/j.jocn.2022.09.007
Autor:
Priya U Kumthekar, Michael J Avram, Andrew B Lassman, Nancy U Lin, Eudocia Lee, Sean A Grimm, Margaret Schwartz, Kirsten L Bell Burdett, Rimas V Lukas, Karan Dixit, Isabella Perron, Hui Zhang, William J Gradishar, Elena I Pentsova, Suriya Jeyapalan, Morris D Groves, Michelle Melisko, Jeffrey J Raizer
Publikováno v:
Neuro-Oncology. 25:557-565
Background Patients with human epidermal growth factor receptor 2-positive (HER2-positive) cancers have a high incidence of central nervous system (CNS) spread, but unfortunately systemic trastuzumab which targets the HER2 receptor has little CNS pen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f77768f1b6a19e682c66e9d528a059e2
https://doi.org/10.1093/neuonc/noac195
https://doi.org/10.1093/neuonc/noac195
Autor:
Priya U, Kumthekar, Michael J, Avram, Andrew B, Lassman, Nancy U, Lin, Eudocia, Lee, Sean A, Grimm, Margaret, Schwartz, Kirsten L, Bell Burdett, Rimas V, Lukas, Karan, Dixit, Isabella, Perron, Hui, Zhang, William J, Gradishar, Elena I, Pentsova, Suriya, Jeyapalan, Morris D, Groves, Michelle, Melisko, Jeffrey J, Raizer
Publikováno v:
Neuro-oncology.
Patients with human epidermal growth factor receptor 2-positive (HER2-positive) cancers have a high incidence of central nervous system (CNS) spread, but unfortunately systemic trastuzumab which targets the HER2 receptor has little CNS penetration. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::948572e4eefb2f070951c8b741c9d2be
https://pubmed.ncbi.nlm.nih.gov/35948282
https://pubmed.ncbi.nlm.nih.gov/35948282